Literature DB >> 28687112

Burden of Illness and Quality-of-Life Measures in Angioedema Conditions.

Teresa Caballero1, Nieves Prior2.   

Abstract

Burden of illness studies and evaluation of health-related quality of life using validated questionnaires have become an important task in the comprehensive management of angioedema conditions, mainly angioedema associated with chronic spontaneous urticaria and hereditary angioedema caused by C1-inhibitor deficiency. A review of the principal tools and studies is presented. Both diseases present a higher proportion of psychiatric disorders, impair work and studies productivity, and produce high direct and indirect costs. These assessments also have been useful to evaluate the positive impact of new drugs and interventions. More studies are desirable, especially in other types of angioedema disorders, such as hereditary angioedema with normal C1 inhibitor.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioedema; Anxiety; Burden; Depression; Health-related quality of life; Patient-reported outcomes; Quality of life

Mesh:

Year:  2017        PMID: 28687112     DOI: 10.1016/j.iac.2017.04.005

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  17 in total

Review 1.  The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews.

Authors:  Milenka Jean-Baptiste; Robbin Itzler; Subhransu Prusty; Dylan Supina; Mona L Martin
Journal:  Orphanet J Rare Dis       Date:  2022-06-16       Impact factor: 4.303

2.  Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.

Authors:  William R Lumry; Karsten Weller; Markus Magerl; Aleena Banerji; Hilary J Longhurst; Marc A Riedl; Hannah B Lewis; Peng Lu; Giovanna Devercelli; Gagan Jain; Marcus Maurer
Journal:  Allergy       Date:  2020-12-24       Impact factor: 13.146

Review 3.  Patient-reported Outcome Measures for Angioedema: A Literature Review.

Authors:  Anna Trier Heiberg Brix; Henrik Balle Boysen; Karsten Weller; Teresa Caballero; Anette Bygum
Journal:  Acta Derm Venereol       Date:  2021-05-19       Impact factor: 3.875

4.  The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.

Authors:  Marcus Maurer; Markus Magerl; Stephen Betschel; Werner Aberer; Ignacio J Ansotegui; Emel Aygören-Pürsün; Aleena Banerji; Noémi-Anna Bara; Isabelle Boccon-Gibod; Konrad Bork; Laurence Bouillet; Henrik Balle Boysen; Nicholas Brodszki; Paula J Busse; Anette Bygum; Teresa Caballero; Mauro Cancian; Anthony J Castaldo; Danny M Cohn; Dorottya Csuka; Henriette Farkas; Mark Gompels; Richard Gower; Anete S Grumach; Guillermo Guidos-Fogelbach; Michihiro Hide; Hye-Ryun Kang; Allen P Kaplan; Constance H Katelaris; Sorena Kiani-Alikhan; Wei-Te Lei; Richard F Lockey; Hilary Longhurst; William Lumry; Andrew MacGinnitie; Alejandro Malbran; Inmaculada Martinez Saguer; Juan José Matta Campos; Alexander Nast; Dinh Nguyen; Sandra A Nieto-Martinez; Ruby Pawankar; Jonathan Peter; Grzegorz Porebski; Nieves Prior; Avner Reshef; Marc Riedl; Bruce Ritchie; Farrukh Rafique Sheikh; William B Smith; Peter J Spaeth; Marcin Stobiecki; Elias Toubi; Lilian Agnes Varga; Karsten Weller; Andrea Zanichelli; Yuxiang Zhi; Bruce Zuraw; Timothy Craig
Journal:  World Allergy Organ J       Date:  2022-04-07       Impact factor: 5.516

Review 5.  Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.

Authors:  Anette Bygum; Paula Busse; Teresa Caballero; Marcus Maurer
Journal:  Front Med (Lausanne)       Date:  2017-12-04

6.  Health-related quality of life and its risk factors in Chinese hereditary angioedema patients.

Authors:  Shuang Liu; Xue Wang; Yingyang Xu; Qun Xu; Yuxiang Zhi
Journal:  Orphanet J Rare Dis       Date:  2019-08-08       Impact factor: 4.123

7.  Evaluation of long-term radiological findings, pulmonary functions, and health-related quality of life in survivors of severe COVID-19.

Authors:  Mustafa Ilteris Bardakci; Esin Nagihan Ozturk; Mufide Arzu Ozkarafakili; Huseyin Ozkurt; Ugur Yanc; Dilek Yildiz Sevgi
Journal:  J Med Virol       Date:  2021-05-31       Impact factor: 20.693

8.  Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.

Authors:  Andrea Zanichelli; Giulia Maria Azin; Federico Cristina; Romualdo Vacchini; Teresa Caballero
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

9.  Predictors of Health-Related Quality of Life and Influencing Factors for COVID-19 Patients, a Follow-Up at One Month.

Authors:  Ke-Yang Chen; Ting Li; Fang-Hua Gong; Jin-San Zhang; Xiao-Kun Li
Journal:  Front Psychiatry       Date:  2020-07-08       Impact factor: 4.157

10.  Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey.

Authors:  Andrea Zanichelli; Markus Magerl; Hilary J Longhurst; Werner Aberer; Teresa Caballero; Laurence Bouillet; Anette Bygum; Anete S Grumach; Jaco Botha; Irmgard Andresen; Marcus Maurer
Journal:  Clin Transl Allergy       Date:  2018-10-12       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.